Hap Trading, LLC Oncocyte Corp Call Options Transaction History

Hap Trading, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 14, 2022	SELL	$2.04 - $3.59 $24,072 - $42,362	-11,800 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$3.53 - $5.89 $74,130 - $123,690	-21,000 Reduced 64.02%	11,800 $3,000
Q2 2021 Aug 11, 2021	SELL	$3.77 - $6.0 $5,655 - $9,000	-1,500 Reduced 4.37%	32,800 $34,000
Q1 2021 May 14, 2021	BUY	$2.39 - $6.5 $36,806 - $100,100	15,400 Added 81.48%	34,300 $44,000
Q4 2020 Feb 16, 2021	BUY	$1.38 - $2.63 $26,081 - $49,707	18,900 New	18,900 $7,000

399K

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $259M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.